Furthermore, BRD4 expression in breast cancer tissues correlates with higher levels of infiltrating myeloid cells (4), and it appears that BRD4 inhibitors may alter the composition of the tumor microenvironment (TME) (12–16). This evidence concerns the gene BRD4 and breast carcinoma.